These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2571175)

  • 1. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH; Hubner CB; Koob GF
    Psychopharmacology (Berl); 1989; 99(1):40-7. PubMed ID: 2571175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):645-8. PubMed ID: 2896363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
    Callaway CW; Geyer MA
    Eur J Pharmacol; 1992 Apr; 214(1):45-51. PubMed ID: 1349861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
    Nash JF; Meltzer HY; Gudelsky GA
    J Neurochem; 1990 Mar; 54(3):1062-7. PubMed ID: 1689375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.
    Yamamoto BK; Spanos LJ
    Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDMA produces stimulant-like conditioned locomotor activity.
    Gold LH; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):352-6. PubMed ID: 2574478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
    Swerdlow NR; Amalric M; Koob GF
    Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.